Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Jul;47(7):613–615. doi: 10.1136/jcp.47.7.613

Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung.

N Watanabe 1, I Nakajima 1, S Abe 1, S Ogura 1, H Isobe 1, Y Kawakami 1
PMCID: PMC502082  PMID: 7522237

Abstract

AIMS--To examine the prognostic value of basement membrane expression in early stage adenocarcinoma of the lung. METHODS--Using antibodies to type IV collagen, basement membrane expression at the tumour-stromal border was immunohistochemically analysed in 30 patients with early stage adenocarcinoma of the lung (pstage I and pstage II). Two patterns of staining for type IV collagen were observed: in the first one the staining line was conserved or partially fragmented; in the second the staining line was widely fragmented or absent in more than 10% of the tumour area. The first staining pattern was categorised as continuous and the second as discontinuous. RESULTS--Of the 24 patients with pstage I adenocarcinoma, 12 (50%) cases showed a continuous pattern. In only one (16.7%) of the six patients with pstage II adenocarcinoma was this pattern evident. Five year survival was greater in pstage I adenocarcinoma (65%) than in pstage II adenocarcinoma (17%), but the difference was not significant. When the analysis was restricted to the 24 patients with pstage I adenocarcinoma, five year survival was better in continuous pattern cases (88%) than in discontinuous pattern cases (20.5%) (p < 0.05). The survival curve of 12 patients with pstage I adenocarcinoma and a discontinuous pattern resembled that of the six patients with pstage II adenocarcinoma. CONCLUSION--These findings suggest that patients with pstage I adenocarcinoma and a discontinuous pattern have histopathologically unrecognised micrometastasis when they come to surgery. The staining pattern of type IV collagen could help in the prognosis of pstage I adenocarcinoma of the lung after surgery.

Full text

PDF
615

Images in this article

614Image
on p.614

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campobasso O., Invernizzi B., Musso M., Berrino F. Survival rates of lung cancer according to histological type. Br J Cancer. 1974 Mar;29(3):240–246. doi: 10.1038/bjc.1974.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chung C. K., Zaino R., Stryker J. A., O'Neill M., Jr, DeMuth W. E., Jr Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis. Ann Thorac Surg. 1982 Jun;33(6):599–604. doi: 10.1016/s0003-4975(10)60819-3. [DOI] [PubMed] [Google Scholar]
  3. Daher N., Abourachid H., Bove N., Petit J., Burtin P. Collagen IV staining pattern in bladder carcinomas: relationship to prognosis. Br J Cancer. 1987 Jun;55(6):665–671. doi: 10.1038/bjc.1987.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grigioni W. F., Biagini G., Garbisa S., D'Errico A., Milani M., Mastrorilli M., Vasi V., Villanacci V., Gozzetti G., Mancini A. M. Immunohistochemical study of basement membrane antigens in bronchioloalveolar carcinoma. Am J Pathol. 1987 Aug;128(2):217–224. [PMC free article] [PubMed] [Google Scholar]
  5. Havenith M. G., Arends J. W., Simon R., Volovics A., Wiggers T., Bosman F. T. Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer. 1988 Nov 15;62(10):2207–2211. doi: 10.1002/1097-0142(19881115)62:10<2207::aid-cncr2820621023>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  6. Isobe H., Miyamoto H., Shimizu T., Haneda H., Hashimoto M., Inoue K., Mizuno S., Kawakami Y. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer. 1990 Mar 15;65(6):1391–1395. doi: 10.1002/1097-0142(19900315)65:6<1391::aid-cncr2820650624>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  7. James R. D., Davey A. T. Mitotic index in carcinoma of the lung. Lancet. 1979 Oct 20;2(8147):852–852. doi: 10.1016/s0140-6736(79)92203-7. [DOI] [PubMed] [Google Scholar]
  8. Liotta L. A., Rao C. N., Barsky S. H. Tumor invasion and the extracellular matrix. Lab Invest. 1983 Dec;49(6):636–649. [PubMed] [Google Scholar]
  9. Lipford E. H., 3rd, Eggleston J. C., Lillemoe K. D., Sears D. L., Moore G. W., Baker R. R. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung. Am J Surg Pathol. 1984 May;8(5):357–365. doi: 10.1097/00000478-198405000-00004. [DOI] [PubMed] [Google Scholar]
  10. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 1988 Sep;96(3):440–447. [PubMed] [Google Scholar]
  11. Shimosato Y., Suzuki A., Hashimoto T., Nishiwaki Y., Kodama T., Yoneyama T., Kameya T. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol. 1980 Aug;4(4):365–373. doi: 10.1097/00000478-198008000-00005. [DOI] [PubMed] [Google Scholar]
  12. Takise A., Kodama T., Shimosato Y., Watanabe S., Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer. 1988 May 15;61(10):2083–2088. doi: 10.1002/1097-0142(19880515)61:10<2083::aid-cncr2820611025>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  13. Valaitis J., Warren S., Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer. 1981 Mar 1;47(5):1042–1046. doi: 10.1002/1097-0142(19810301)47:5<1042::aid-cncr2820470535>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  14. Vincent R. G., Pickren J. W., Lane W. W., Bross I., Takita H., Houten L., Gutierrez A. C., Rzepka T. The changing histopathology of lung cancer: a review of 1682 cases. Cancer. 1977 Apr;39(4):1647–1655. doi: 10.1002/1097-0142(197704)39:4<1647::aid-cncr2820390439>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  15. Williams D. E., Pairolero P. C., Davis C. S., Bernatz P. E., Payne W. S., Taylor W. F., Uhlenhopp M. A., Fontana R. S. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg. 1981 Jul;82(1):70–76. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES